Skip to content

Unilife Medical Solutions

Company Profile


Unilife is a U.S. based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for our products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. All of our syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. We are ISO 13485 certified and have FDA-registered medical device manufacturing facilities in Pennsylvania.

Our main product is the UnifillTM ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with their injectable drugs and vaccines. We have a strategic partnership with sanofi-aventis, who has the exclusive right to negotiate for the purchase of the Unifill syringe and is funding our industrialization program. In addition, we have retained the right to negotiate with other pharmaceutical companies seeking to utilize the Unifill syringe with drugs and vaccines marketed in therapeutic areas outside of those secured exclusively by sanofi-aventis.

Financial Information
Financial Summary
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Stock Information
Stock Performance
Historic Stock Lookup
Investment Calculator
Analyst Coverage
ASX Stock Data
News and Events
Press Releases
Events
Presentations
Corporate Governance
Introduction
Management
Board of Directors
Committee Composition
Policies and Guidelines
Ethics Hotline
Contact the Board
Investor Facts
Trading on Unilife FAQ
Tax Ruling
Contact Us
Contact Us


NASDAQ:UNIS
Date  Feb 3, 2012
Time  4:00 PM ET
Last Price  $3.87
Change  -
Quotes delayed at least 20 minutes.
Information provided by eSignal.